New biomarkers of injury, inflammation and remodeling in the differential diagnosis of heart failure types
Heart failure (HF) is a global pandemic that is steadily increasing in prevalence. Currently, based on the left ventricular ejection fraction, three types of HF are distinguished. A theory was created that the HF pathophysiology is based on two processes: systolic and diastolic myocardial dysfunctio...
Main Authors: | E. K. Serezhina, A. G. Obrezan |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2021-02-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/3914 |
Similar Items
-
Promising Novel Biomarkers in Cardiovascular Diseases
by: Brigitte Sipos, et al.
Published: (2021-04-01) -
Multimarker approach including CRP, sST2 and GDF‐15 for prognostic stratification in stable heart failure
by: Nils Kuster, et al.
Published: (2020-10-01) -
Growth differentiation factor 15 as mortality predictor in heart failure patients with non‐reduced ejection fraction
by: Ana Belen Mendez Fernandez, et al.
Published: (2020-10-01) -
New Cardiovascular Biomarkers in Ischemic Heart Disease—GDF-15, A Probable Predictor for Ejection Fraction
by: Daniel Dalos, et al.
Published: (2019-06-01) -
Growth differentiation factor‐15, treatment with liraglutide, and clinical outcomes among patients with heart failure
by: Abhinav Sharma, et al.
Published: (2021-08-01)